Suryakumar Yadav dropped! BCCI names Shreyas Iyer new T20I captain unveiling India squad for Asian Games, and tour of Ireland and EnglandJune 6, 2026
Servier Moves Into Muscular Dystrophy, Paying $1.5B for Assets From Edgewise TherapeuticsNews DeskJune 1, 20260 Servier is expanding its scope in neurology to include neuromuscular disorders by acquiring a clinical-stage Edgewise Therapeutics drug that offers…
Regeneron Cancer Drug Shows New Promise in a Rare Disease… and Maybe MoreNews DeskJune 1, 20260 In the rare blood disorder light chain amyloidosis, standard treatment is a drug combination used for a blood cancer. It’s…
AbbVie’s ADC Strategy Notches Another Win With FDA Approval in Ultra-Rare Blood CancerNews DeskMay 28, 20260 AbbVie’s strategy of growing in oncology by focusing on a particular type of targeted therapy is paying off with another…
BioMarin’s Mixed Bag of Phase 3 Data Dim Prospects for Rare Disease DrugNews DeskMay 19, 20260 A BioMarin Pharmaceutical deal last year brought the company a late-stage therapy that fit the company’s extensive enzyme replacement experience…
Angelini Pharma’s $4B Acquisition Adds Rare Disease Drugs to a Global Growth StrategyNews DeskMay 7, 20260 Angelini Pharma is acquiring Catalyst Pharmaceuticals in a $4.1 billion deal that gives the Italy-based brain medicines company three commercialized…